We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
AtriCure
ATRC
$2.01B
| $13.5M | 0.03% |
300,000
-600,000
| -67% | -$26.1M |
|
477
Atmos Energy
ATO
$29.1B
| $13.4M | 0.03% |
134,965
-299,311
| -69% | -$30.2M |
|
478
Teledyne Technologies
TDY
$31.9B
| $13.4M | 0.03% |
+43,100
| New | +$14.2M |
|
|
TMX
479
DELISTED
Terminix Global Holdings, Inc.
TMX
| $13.3M | 0.03% |
+373,499
| New | +$11.5M |
|
|
WCN
480
Waste Connections
WCN
$42.2B
| $13.3M | 0.03% |
141,928
-18,900
| -12% | -$1.68M |
|
481
Extra Space Storage
EXR
$31.6B
| $13.3M | 0.03% |
144,000
-2,300
| -2% | -$214K |
|
482
Eagle Materials
EXP
$6.48B
| $13.3M | 0.03% |
+189,200
| New | +$11.9M |
|
483
Southern Company
SO
$107B
| $13.2M | 0.03% |
253,718
-947,900
| -79% | -$52.7M |
|
484
J.M. Smucker
SJM
$12.7B
| $13.1M | 0.03% |
124,027
-2,900
| -2% | -$326K |
|
|
NVO
485
Novo Nordisk
NVO
$203B
| $13.1M | 0.03% |
400,000
-400,000
| -50% | -$12.8M |
|
486
Alliant Energy
LNT
$18B
| $13M | 0.03% |
271,566
-5,300
| -2% | -$258K |
|
487
Brown-Forman Class B
BF.B
$13B
| $13M | 0.03% |
203,632
-3,700
| -2% | -$236K |
|
488
Jacobs Solutions
J
$16.9B
| $12.9M | 0.03% |
183,673
-2,901
| -2% | -$196K |
|
489
NVR
NVR
$16.8B
| $12.7M | 0.03% |
3,900
-100
| -3% | -$307K |
|
490
Western Digital
WDC
$156B
| $12.7M | 0.03% |
380,411
+63,504
| +20% | +$2.06M |
|
491
Expedia Group
EXPE
$36.8B
| $12.7M | 0.03% |
153,900
-2,500
| -2% | -$182K |
|
492
CrowdStrike
CRWD
$211B
| $12.5M | 0.03% |
500,000
-20,000
| -4% | -$401K |
|
|
CTXS
493
DELISTED
Citrix Systems Inc
CTXS
| $12.5M | 0.03% |
84,200
-37,300
| -31% | -$5.37M |
|
494
Snap
SNAP
$8.83B
| $12.3M | 0.03% |
+525,000
| New | +$9.34M |
|
495
C.H. Robinson
CHRW
$17.1B
| $12.3M | 0.03% |
155,400
+35,100
| +29% | +$2.65M |
|
496
UDR
UDR
$12.3B
| $12.3M | 0.03% |
327,800
-5,700
| -2% | -$213K |
|
497
Inspire Medical Systems
INSP
$1.7B
| $12.2M | 0.03% |
140,000
-160,000
| -53% | -$12.3M |
|
|
AKUS
498
DELISTED
Akouos Inc
AKUS
| $12.2M | 0.03% |
+540,000
| New | +$12M |
|
499
Wabtec
WAB
$49.9B
| $12.1M | 0.03% |
210,100
+56,783
| +37% | +$3.22M |
|
|
ARNA
500
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $12M | 0.03% |
190,000
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.